WaferGen Biosystems, Inc. (OTC: WGBS) develops, manufactures and sells systems for gene expression quantification, genotyping and stem cell research for the life sciences and pharmaceutical drug discovery industries in the United States, Canada, Europe and the Asia Pacific. The company offers SmartChip Real-Time PCR system, which provides a suite of gene expression and genome analysis technologies enabling biomarker discovery and validation on a single platform with the sensitivity and accuracy of real-time polymerase chain reaction (PCR). For more information, visit the company’s website at www.wafergen.com.